[Federal Register Volume 65, Number 90 (Tuesday, May 9, 2000)]
[Notices]
[Pages 26868-26869]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-11497]


-----------------------------------------------------------------------

SMALL BUSINESS ADMINISTRATION


Notice Seeking Exemption Under Section 312 of the Small Business 
Investment Act, Conflicts of Interest

    Notice is hereby given that TD Origen Fund, L.P. (``TD Origen''), 
150 Washington Avenue, Suite 201, Santa Fe, New Mexico 87501, a Federal 
Licensee under the Small Business Investment Act of 1958, as amended 
(``the Act''), TD Javelin Capital Fund, LP (``TD Javelin I''), 2850 
Cahaba Road, Suite 240, Birmingham, Alabama 35223, a Federal Licensee 
under the Act, and TD Javelin Capital Fund II, LP (``TD Javelin II''), 
2850 Cahaba Road, Suite 240, Birmingham, Alabama 35223 (collectively 
``the Funds''), in connection with the financing of a small concern, 
have sought an exemption under section 312 of the Act and section 
107.730, Financings which Constitute Conflicts of Interest of the Small 
Business Administration (``SBA'') rules and regulations (13 CFR 107.730 
(2000)). The Funds propose to provide equity financing to Phase-1 
Molecular Toxicology, Inc. (``Phase-1''), 2904 Rodeo Park Drive East, 
Santa Fe, New Mexico 97505. The financing is contemplated for product 
development and working capital.
    The financing is brought within the purview of Sec. 107.730(a)(1) 
of the

[[Page 26869]]

Regulations because TD Origen and TD Javelin, Associates of the Funds, 
currently own greater than 10 percent of Phase-1 and therefore Phase-1 
is considered an Associate of each of the Funds as defined in Sec. 
107.50 of the regulations.
    Notice is hereby given that any interested person may submit 
written comments on the transaction to the Associate Administrator for 
Investment, U.S. Small Business Administration, 409 Third Street, SW, 
Washington, DC 20416.

    Dated: April 26, 2000.
Don A. Christensen,
Associate Administrator for Investment.
[FR Doc. 00-11497 Filed 5-8-00; 8:45 am]
BILLING CODE 8025-01-P